Literature DB >> 27539167

Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson's Disease.

Adam Nassery1, Christina A Palmese2, Harini Sarva3, Mark Groves2, Joan Miravite2,4, Brian Harris Kopell5.   

Abstract

Deep brain stimulation (DBS) is effective for Parkinson's disease (PD), dystonia, and essential tremor (ET). While motor benefits are well documented, cognitive and psychiatric side effects from the subthalamic nucleus (STN) and globus pallidus interna (GPi) DBS for PD are increasingly recognized. Underlying disease, medications, microlesions, and post-surgical stimulation likely all contribute to non-motor symptoms (NMS).

Entities:  

Keywords:  Affective disorders; Cognition; Deep brain stimulation; Parkinson’s disease

Mesh：

Year:  2016        PMID： 27539167     DOI： 10.1007/s11910-016-0690-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


  99 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

2.  Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.

Authors:  L Castelli; P Perozzo; M Zibetti; B Crivelli; U Morabito; M Lanotte; F Cossa; B Bergamasco; L Lopiano
Journal:  Eur Neurol       Date:  2006-05-08       Impact factor: 1.710

3.  Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson's disease.

Authors:  Karsten Witt; Christine Daniels; Jan Herzog; Delia Lorenz; Jens Volkmann; Julia Reiff; Maximilian Mehdorn; Günther Deuschl; Paul Krack
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

4.  Pathological crying after subthalamic nucleus stimulation.

Authors:  Pornjira Pariwatcharakul; Chris Clough; Paul Shotbolt; Robert Morris; Natasha Hulse; Angela Costello; Michael Samuel; Keyoumars Ashkan
Journal:  Mov Disord       Date:  2013-07-18       Impact factor: 10.338

5.  Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.

Authors:  D F Marshall; A M Strutt; A E Williams; R K Simpson; J Jankovic; M K York
Journal:  Eur J Neurol       Date:  2012-05-26       Impact factor: 6.089

Review 6.  Depression and anxiety following deep brain stimulation in Parkinson's disease: systematic review and meta-analysis.

Authors:  Maria Inês Couto; Ana Monteiro; Ana Oliveira; Nuno Lunet; João Massano
Journal:  Acta Med Port       Date:  2014-06-30

7.  Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up.

Authors:  P Amami; I Dekker; S Piacentini; F Ferré; L M Romito; A Franzini; E M J Foncke; A Albanese
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-07-10       Impact factor: 10.154

8.  Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease.

Authors:  Selma Aybek; Aline Gronchi-Perrin; Alexandre Berney; Sabina Catalano Chiuvé; Jean-Guy Villemure; Pierre R Burkhard; François J G Vingerhoets
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

9.  Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial.

Authors:  Daniel Weintraub; John E Duda; Kimberly Carlson; Ping Luo; Oren Sagher; Matthew Stern; Kenneth A Follett; Domenic Reda; Frances M Weaver
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-05-10       Impact factor: 10.154

10.  Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study.

Authors:  L Castelli; M Lanotte; M Zibetti; M Caglio; L Rizzi; A Ducati; B Bergamasco; L Lopiano
Journal:  J Neurol       Date:  2007-04-11       Impact factor: 4.849
View more
  7 in total

1.  Cognitive outcome following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease-a comparative observational study in Indian patients.

Authors:  Kshiteeja Jain; Remya Ramesh; Syam Krishnan; Krishnakumar Kesavapisharady; K P Divya; Sankara P Sarma; Asha Kishore
Journal:  Acta Neurol Belg       Date:  2021-08-26       Impact factor: 2.396

2.  DBS-Edmonton App, a Tool to Manage Patient Expectations of DBS in Parkinson Disease.

Authors:  Kevin Yen; Janis M Miyasaki; Michelle Waldron; Lin Yu; Tejas Sankar; Fang Ba
Journal:  Neurol Clin Pract       Date:  2021-06

Review 3.  Deep Brain Stimulation in Parkinson Disease: A Meta-analysis of the Long-term Neuropsychological Outcomes.

Authors:  Madalina Bucur; Costanza Papagno
Journal:  Neuropsychol Rev       Date:  2022-03-23       Impact factor: 6.940

4.  Distinct roles of dorsal and ventral subthalamic neurons in action selection and cancellation.

Authors:  Clayton P Mosher; Adam N Mamelak; Mahsa Malekmohammadi; Nader Pouratian; Ueli Rutishauser
Journal:  Neuron       Date:  2021-01-21       Impact factor: 17.173

Review 5.  A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway.

Authors:  Didier Pinault
Journal:  Brain Sci       Date:  2017-03-28

6.  Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.

Authors:  Sandra Kurcova; Jan Bardon; Miroslav Vastik; Marketa Vecerkova; Monika Frolova; Lenka Hvizdosova; Martin Nevrly; Katerina Mensikova; Pavel Otruba; David Krahulik; Egon Kurca; Stefan Sivak; Jana Zapletalova; Petr Kanovsky
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

7.  Subthalamic Deep Brain Stimulation Affects Plasma Corticosterone Concentration and Peripheral Immunity Changes in Rat Model of Parkinson's Disease.

Authors:  Beata Grembecka; Wojciech Glac; Magdalena Listowska; Grażyna Jerzemowska; Karolina Plucińska; Irena Majkutewicz; Piotr Badtke; Danuta Wrona
Journal:  J Neuroimmune Pharmacol       Date:  2020-07-09       Impact factor: 4.147
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.